EAM
ORIC icon

Eventide Asset Management’s Oric Pharmaceuticals ORIC Stock Holding History

Eventide Asset Management’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.1M Buy
953,451
+1,080
+0.1% +$12.3K 0.2% 128
2025
Q4 		$7.79M Buy
952,371
+864
+0.1% +$9.95K 0.12% 154
2025
Q3 		$11.4M Buy
951,507
+74
+0% +$779 0.19% 123
2025
Q2 		$9.66M Buy
+951,433
New +$6.39M 0.17% 128
2021
Q4 		– Sell
-724,972
Closed -$15.2M – 155
2021
Q3 		$15.2M Sell
724,972
-151,976
-17% -$3.08M 0.2% 114
2021
Q2 		$15.5M Buy
876,948
+446,948
+104% +$9.79M 0.21% 105
2021
Q1 		$10.5M Hold
430,000
– – 0.16% 116
2020
Q4 		$14.6M Buy
+430,000
New +$12.3M 0.23% 100

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $22.1B AUM 51.63% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return